- Senegal has a disease called Rift Valley fever.
- This disease affects people and animals.
- Senegal is working to stop the disease.
- Self-medication can be dangerous.
- People should see a doctor if they feel sick.
- Vaccination helps protect animals from the disease.
Difficult words
- disease — A health problem that can affect people.
- affect — To have an effect on someone or something.affects
- stop — To make something come to an end.
- dangerous — Able to cause harm or injury.
- doctor — A person who helps people with health problems.
- vaccination — A shot to protect from disease.
- protect — To keep someone or something safe.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do you think self-medication can be dangerous?
- How can vaccinations help prevent disease?
Related articles
Rethinking Health Finance in Africa at UN Talks
African leaders aim to change health funding at UN meetings. They emphasize self-reliance and need for better local investment.
Rural Doctor Shortage Has Gotten Worse
A study shows increasing difficulty in accessing family physicians in rural areas of the US. This shortage is significant as young adults move to these areas.
African Diet Reduces Inflammation in Two Weeks
A traditional African diet can help lower inflammation and improve health in just two weeks, unlike Western diets, which can worsen health issues.
Cocoa Growers and Agroforestry Challenges
Cocoa growers are hesitant to adopt agroforestry despite its benefits for the environment and crop resilience.
Save Sagea Coalition Defends Community and Environment Against Mining Companies
The Save Sagea coalition, led by activist Adlunfiqri Sigoro, is fighting against mining companies in Indonesia to protect their land and environment. Their protests highlight risks to local culture and livelihoods.
Broader Access Urged for Affordable HIV Drug
Campaigners are urging for broader access to a new affordable HIV prevention drug known as lenacapavir, which will be available in many low- and middle-income countries.